Snowden Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.87M Sell
7,074
-381
-5% -$155K 0.08% 239
2025
Q1
$3.71M Sell
7,455
-197
-3% -$98.1K 0.12% 187
2024
Q4
$3.98M Sell
7,652
-874
-10% -$455K 0.12% 176
2024
Q3
$5.28M Sell
8,526
-245
-3% -$152K 0.16% 154
2024
Q2
$4.85M Sell
8,771
-164
-2% -$90.8K 0.14% 179
2024
Q1
$5.2M Buy
8,935
+3,522
+65% +$2.05M 0.16% 167
2023
Q4
$2.87M Sell
5,413
-428
-7% -$227K 0.11% 231
2023
Q3
$2.96M Sell
5,841
-7,379
-56% -$3.74M 0.13% 216
2023
Q2
$6.9M Sell
13,220
-462
-3% -$241K 0.25% 96
2023
Q1
$7.89M Buy
13,682
+174
+1% +$100K 0.31% 69
2022
Q4
$7.44M Buy
13,508
+1,408
+12% +$775K 0.31% 68
2022
Q3
$6.14M Sell
12,100
-245
-2% -$124K 0.28% 80
2022
Q2
$6.71M Buy
12,345
+305
+3% +$166K 0.3% 75
2022
Q1
$7.11M Buy
12,040
+2,636
+28% +$1.56M 0.28% 81
2021
Q4
$6.28M Sell
9,404
-2,547
-21% -$1.7M 0.32% 80
2021
Q3
$6.83M Buy
11,951
+141
+1% +$80.6K 0.34% 68
2021
Q2
$5.96M Buy
11,810
+662
+6% +$334K 0.3% 81
2021
Q1
$5.09M Sell
11,148
-9,266
-45% -$4.23M 0.29% 91
2020
Q4
$9.51M Buy
20,414
+1,475
+8% +$687K 0.63% 20
2020
Q3
$8.36M Buy
18,939
+6,624
+54% +$2.92M 0.67% 21
2020
Q2
$4.46M Buy
12,315
+3,438
+39% +$1.25M 0.38% 71
2020
Q1
$2.52M Buy
8,877
+181
+2% +$51.3K 0.27% 113
2019
Q4
$2.83M Buy
8,696
+148
+2% +$48.1K 0.25% 127
2019
Q3
$2.49M Sell
8,548
-157
-2% -$45.7K 0.25% 138
2019
Q2
$2.56M Sell
8,705
-139
-2% -$40.8K 0.26% 136
2019
Q1
$2.42M Buy
8,844
+43
+0.5% +$11.8K 0.26% 134
2018
Q4
$1.97M Buy
8,801
+135
+2% +$30.2K 0.26% 139
2018
Q3
$2.12M Buy
8,666
+205
+2% +$50K 0.24% 137
2018
Q2
$1.75M Buy
8,461
+81
+1% +$16.8K 0.23% 156
2018
Q1
$1.73M Buy
8,380
+6,994
+505% +$1.44M 0.25% 144
2017
Q4
$263K Buy
1,386
+77
+6% +$14.6K 0.04% 347
2017
Q3
$248K Buy
+1,309
New +$248K 0.04% 336
2017
Q2
Sell
-1,360
Closed -$209K 364
2017
Q1
$209K Buy
+1,360
New +$209K 0.05% 316